ROLE OF BASOPHILIC LEUKOCYTES IN INFLAMMATORY SKIN DISEASES

被引:3
作者
AMON, U
DIECKMANN, D
NITSCHKE, N
WEHRHAHN, C
WOLFF, HH
机构
来源
HAUTARZT | 1995年 / 46卷 / 04期
关键词
BASOPHILIC LEUKOCYTES; ATOPIC DERMATITIS; LATE PHASE REACTION; ALLERGIC CONTACT DERMATITIS; JONES-MOTE REACTION;
D O I
10.1007/s001050050246
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Basophilic leukocytes are effector cells of the peripheral blood. They have several morphological and functional characteristics in common with tissue mast cells, such as expression of the high-affinity IgE receptor (Fc(epsilon)RI) and a high content of histamine within their granules. Functional comparison of human basophils and human mast cells isolated from different tissues revealed marked heterogeneity of mediator release after incubation with different secretagogues. Owing to their wide range of surface receptors, their (pro)inflammatory mediators released after activation, their mobility, and their rapid turnover, basophils appear basically to be potent effector cells, which migrate transiently into the skin during IgE-mediated (and/or IgE-independent) inflammatory reactions. The present paper reviews recent findings on the possible role of basophils for different immune reactions of the skin. Inhibition of basophil (and/or mast cell) activity seems to be necessary for both effective prophylaxis and therapy of allergic and inflammatory skin diseases. To date, however, the pharmacological modulation of mediator release from basophils lacks potent clinically useful compounds that can suppress the cellular response, since mast cell stabilizers such as cromoglycate and nedocromil are not effective. With a view to the development of active compounds, further in vitro studies should focus on the mechanisms of cell activation.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 44 条
  • [31] Metcalfe DD, 1992, INFLAMMATION BASIC P
  • [32] INCREASE IN SKIN MAST-CELLS FOLLOWING CHRONIC HOUSE DUST MITE EXPOSURE
    MITCHELL, EB
    CROW, J
    WILLIAMS, G
    PLATTSMILLS, TAE
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1986, 114 (01) : 65 - 73
  • [33] MITCHELL EB, 1982, LANCET, V1, P127
  • [34] MITCHELL EB, 1983, CLIN REV ALLERG, V1, P427
  • [35] OKAYAMA Y, 1993, HDB PHARM, P139
  • [36] PEARCE FL, 1988, MAST CELLS MEDIATORS, P175
  • [37] PLASMA HISTAMINE CONCENTRATIONS IN ATOPIC ECZEMA
    RING, J
    [J]. CLINICAL ALLERGY, 1983, 13 (06): : 545 - 552
  • [38] THE MAST-CELL IN HEALTH AND DISEASE
    ROTHE, MJ
    NOWAK, M
    KERDEL, FA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (04) : 615 - 624
  • [39] INCREASED PLASMA TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATION IN ATOPIC-DERMATITIS
    SUMIMOTO, S
    KAWAI, M
    KASAJIMA, Y
    HAMAMOTO, T
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (03) : 277 - 279
  • [40] HISTAMINE-METABOLISM IN DELAYED-TYPE HYPERSENSITIVITY - COMPARATIVE-ANALYSIS WITH CELLULAR INFILTRATES
    TACHIBANA, T
    TODA, KI
    FURUKAWA, F
    TANIGUCHI, S
    IMAMURA, S
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1990, 282 (04) : 217 - 222